Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the DNA-testing company after a nonprofit ...

Teva collaboration agreement aims to accelerate clinical data generation for TEV-56278 and develop Anti-PD1-IL2 Therapy.

Ecolab has launched a new resin designed to help achieve cost savings and optimize operations throughout the antibody ...

How can early decisions in cell and gene therapy clinical development impact downstream progress toward commercialization and ...

Looking at key trends in outsourcing, manufacturing, and regulatory compliance. Embracing innovation, flexibility, and talent ...

Advanced technologies and close collaboration maximize yields, safety, and patient access to life-saving therapies.

How specialized expertise, advanced infrastructure, and strategic partnerships are enabling the next generation of cell-based ...

BioNTech has agreed to acquire CureVac, a clinical-stage biotech company developing a novel class of transformative medicines ...

Nuvation Bio Inc., a global oncology company, received U.S. Food and Drug Administration (FDA) approval of Ibtrozi ...

Novo Nordisk and Deep Apple Therapeutics Inc. have entered a research collaboration and exclusive license agreement.

Merck also introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable locally advanced head ...

The research program will combine Debiopharm’s AbYlink conjugation technology with Alkyon’s modular antibody platform and ...